泌尿男生殖系肿瘤第七版TNM分期的变化及解读
被引量:10
摘要
目前,恶性肿瘤已成为威胁人类健康与生命的主要疾病之一。在发达国家,恶性肿瘤是国民死亡的首要原因。在我国,恶性肿瘤占城市居民死因的第一位,在农村居民的死因中也呈上升趋势。
出处
《中华泌尿外科杂志》
CAS
CSCD
北大核心
2012年第2期149-151,共3页
Chinese Journal of Urology
参考文献19
-
1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61: 69-90.
-
2Farges O, Fuks D, Le Treut YP, et al. AJCC 7th edition of TNM staging accu- rately discriminates outcomes of patients with resectable intrahepatic cholangiocar- cinoma: by the AFC-IHCC-2009 study group. Cancer, 2011, 117: 2170-2177.
-
3Hong KD, Lee SI, Moon HY. Lymph node ratio as determined by the 7th edi- tion of the Ameriean Joint Committee on Cancer staging system predicts survival in stage III colon cancer. J Surg Oncol', 2011, 103: 406-410.
-
4Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th ed. Singapore: Wiley- Blackwell, 2009.
-
5Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual 7th ed. New York: Springer Verlag, 2010.
-
6牛海涛,孙光.根治性膀胱切除手术预后评价的研究进展[J].中华泌尿外科杂志,2011,32(10):718-720. 被引量:4
-
7Lotan Y, Gupta A, Shariat SF, et al. Lymphovascular invasion is independent- ly associated with overall survival, cause-specific survival, and local and distant recurrence in patients with nega- tive lymph nodes at radical cystectomy. J Clin Oncol, 2005, 23: 6533-6539.
-
8Bhagat SK, Gopalakrishnan G, Kekre NS, et al. Factors predicting inguinal node metastasis in squamous cell cancer of penis. World J Urol, 2010, 28: 93- 98.
-
9Thuret R, Sun M, Abdollah F, et al. Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile car- cinoma. J Urol, 2011, 185: 501-507.
-
10Deem S, Keane T, Bhavsar R, et al. Contemporary diagnosis and management of squamous cell carcinoma (SCC) of the penis. BJU Int, 2011, 108: 1378- 1392.
二级参考文献20
-
1Shariat SF, Palapattu GS, Karakiewicz PI, et al. Discrepancy between clinical and pathologic stage: impact on progno- sis after radical cystcctomy. Eur Urol, 2007, 51: 137-149.
-
2Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term re- suits in 1054 patients. J Clin Oncol, 2001, 19 : 666-675.
-
3Kaufman DS, Shipley WU, Fcldnaan AS. madder cancer. Lancet, 2009, 374: 239 -249.
-
4Bruins HM, Stein JP. Risk factors and clinical outcomes of patients with node- positive muscle-invasive bladder cancer. Expert Rev Anticancer Ther, 2008, 8: 1091-1101.
-
5Stein JP. The role of lymphadenectomy in patients undergoing radical eystecto- my for bladder cancer. Curr Oncol Rep, 2007, 9: 213-221.
-
6el-Mekresh M, Akl A, Mosbah A, et al. Prediction of survival after radical cystectomy for invasive bladder carcino- ma: risk group stratification, nomo- grams or artificial neural networks? J Urol, 2009, 182: 466-4-72.
-
7Niu HT, Xu T, Zhang YB, et al. Out- comes for a large series of radical cystec- tomies for bladder cancer. Eur J Surg Oncol, 2008, 34: 911-915.
-
8Rogers CG, Palapattu GS, Shariat SF, et al. Clinical outcomes following radical cystectomy for primary nontransitioaal cell carcinoma of the bladder compared to transitional cell carcinoma of the blad- der. J Urol, 2006, 175: 2048-2053.
-
9Lee CT, Madii R, Daignauh S, et al. Cystectomy delay more than 3 months from initial bladder cancer diagnosis re- suits in decreased disease specific and o- verall survival. J Urol, 2006, 175: 1262-1267.
-
10Sanchez-Ortiz RF, Huang WC, Mick R, et al. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol, 2003. 169, 110-115.
共引文献3
-
1喻希,葛鹏,王子成,林健.根治性膀胱切除标本中淋巴血管侵犯的预后判断价值研究[J].中华泌尿外科杂志,2015,36(2):122-125. 被引量:10
-
2王铃,石林,郑石磊,李鹏飞,张祥林.膀胱影像报告和数据系统对膀胱癌组织病理学特征的诊断价值[J].中国医学影像学杂志,2021,29(11):1109-1113. 被引量:4
-
3陈超,郭学文,唐冬雪,曹延炜,牛海涛.基于人工神经网络数据挖掘技术构建浸润性膀胱癌预后模型研究[J].泌尿外科杂志(电子版),2015,7(2):38-42. 被引量:1
同被引文献88
-
1Soichiro Yoshida,Fumitaka Koga,Shuichiro Kobayashi,Hiroshi Tanaka,Shiro Satoh,Yasuhisa Fujii,Kazunori Kihara.Diffusion-weighted magnetic resonance imaging in management of bladder cancer, particularly with multimodal bladder-sparing strategy[J].World Journal of Radiology,2014,6(6):344-354. 被引量:2
-
2方祖军,燕翔,郑捷,杨醌,陈波,姚孟树,丁强,张元芳.肾癌的病理类型与预后的关系[J].临床泌尿外科杂志,2006,21(4):262-263. 被引量:22
-
3Siegel R,Naishadham D,Jemal A.Cancer statistics,2013.CA Cancer J Clin,2013,63:11-30.
-
4Smith MR,Saad F,Coleman R,et al.Denosumab and bonemetastasis-free survival in men with castration-resistant prostate cancer:results of a phase 3,randomised,placebo-controlled trial.Lancet,2012,379:39-46.
-
5Makarov DV,Trock BJ,Humphreys EB,et al.Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level,clinical stage,and biopsy Gleason score (Partin tables)based on cases from 2000 to 2005.Urology,2007,69:1095-1101.
-
6Jeldres C,Suardi N,Walz J,et al.Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.Eur Urol,2008,54:1306-1313.
-
7Stephenson AJ,Kattan MW,Eastham JA,et al.Prostate cancerspecific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.J Clin Oncol,2009,27:4300-4305.
-
8Cagiannos I,Karakiewicz P,Eastham JA,et al.A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.J Urol,2003,170:1798-1803.
-
9Tosoian J J,Trock B J,Landis P,et al.Active surveillance program for prostate cancer:an update of the Johns Hopkins experience.J Clin Oneol,2011,29:2185-2190.
-
10Kitagawa Y,Ueno S,Izumi K,et al.Cumulative probability of prostate cancer detection in biopsy according to free/total PSA ratio in men with total PSA levels of 2.1-10.0 ng/ml at population screening.J Cancer Res Clin Oncol,2013 Oct 29.[Epub ahead of print].
引证文献10
-
1郭放,刘兆喆,谢晓冬.NCCN前列腺癌临床治疗指南更新要点解读与探讨[J].中华泌尿外科杂志,2013,34(12):949-951. 被引量:11
-
2王功伟,王颖,陈云新,胡浩,沈丹华.705例肾细胞癌临床病理学特征初步研究[J].中华泌尿外科杂志,2014,35(4):254-257. 被引量:7
-
3张娟,王功伟,丁彩霞,黄颖楠.透明细胞(管状)乳头状肾细胞癌临床病理学分析[J].临床与病理杂志,2014,34(4):358-363. 被引量:5
-
4王功伟,胡浩,沈丹华.不同肾细胞癌亚型临床病理学特征比较[J].国际泌尿系统杂志,2015,35(1):33-37. 被引量:2
-
5张巍,王志斌,张乐,李迎春.多参数核磁共振技术全面性诊断膀胱癌临床价值[J].实用医学杂志,2018,34(6):1010-1015. 被引量:14
-
6赵志强,朱帅科,高建凯.淋巴管浸润对上尿路尿路上皮癌患者预后的影响[J].河南医学研究,2018,27(18):3298-3300.
-
7房昆仑,林涛,范晓军,张叶,李想,袁明远.核磁共振多参数成像技术对膀胱癌T分期的诊断价值评估[J].国际泌尿系统杂志,2019,39(5):791-795. 被引量:12
-
8赵世明,杨铁军,许春苗,郭孝峰,马永康,陈学军,李祥,何朝宏.3.0T磁共振成像在接受过经尿道膀胱肿瘤切除术膀胱癌中诊断肌层浸润的应用[J].北京大学学报(医学版),2020,52(4):701-704. 被引量:7
-
9王艳,白玫,李伟.高场强多参数MRI与多层螺旋CT对膀胱癌术前T分期的诊断效能比较[J].中国实验诊断学,2022,26(7):1001-1005. 被引量:6
-
10高晓峰,葛海兰,康晓霞,火妍,聂蕾蕾.MRI联合多层螺旋CT在膀胱癌诊断和分期中的应用价值[J].宁夏医学杂志,2023,45(9):850-852. 被引量:1
二级引证文献58
-
1张娟,王功伟,丁彩霞,黄颖楠.透明细胞(管状)乳头状肾细胞癌临床病理学分析[J].临床与病理杂志,2014,34(4):358-363. 被引量:5
-
2杨晓群,苗娜,甘华磊,王磊,王朝夫.透明细胞乳头状肾细胞癌的临床病理特征[J].中华病理学杂志,2015,44(6):372-376. 被引量:10
-
3张志林,宋晓,崔书君,邹殿俊,朱晓龙,耿鹤群.64排螺旋CT诊断肾细胞癌120例临床价值探讨[J].陕西医学杂志,2016,45(1):40-42. 被引量:6
-
4翁亚菡.前列腺穿刺标本行 P504 s、P63、CK34βE12免疫组化检测的临床价值分析[J].中国实用医刊,2016,43(1):69-70. 被引量:3
-
5李应龙,曾凯,王勤章.肾脏小体积占位的自然史和临床处理[J].现代泌尿外科杂志,2016,21(5):329-333.
-
6曲静坤.比卡鲁胺联合戈舍瑞林间歇性治疗局部晚期前列腺癌的临床评价[J].中国药业,2016,25(11):46-48. 被引量:14
-
7邱敏,卢剑,马潞林,陆敏,赵磊,侯小飞,王国良,邓绍晖,颜野.透明细胞乳头状肾细胞癌的诊治经验[J].中华泌尿外科杂志,2016,37(9):655-659. 被引量:3
-
8刘洪斌.骨扫描和MRI诊断前列腺癌骨转移的临床价值比较[J].医药论坛杂志,2016,37(11).
-
9王小明,王颖.对比分析不同肾细胞癌亚型的临床病理学特征[J].热带医学杂志,2016,16(11):1389-1392. 被引量:1
-
10李江,邱雁,邱梁.混合型抗体EZH2/34βE12/p63在前列腺穿刺标本中的诊断意义[J].实用老年医学,2017,31(5):458-460. 被引量:1
-
1王国民,朱延军.DNA甲基化在泌尿系统肿瘤中的研究及应用[J].中华实验外科杂志,2009(10):1241-1243. 被引量:2
-
2牛淑媛,高婉萍,周西.北京地区女性生殖系统恶性肿瘤死亡回顾调查分析[J].北京医学,1989,11(5):266-268.
-
3宁浩勇.人绒毛膜促性腺激素在非生殖系统肿瘤中的表达及其临床病理意义[J].诊断病理学杂志,1998,5(4):231-232. 被引量:2
-
4靳风烁.重视泌尿男生殖系肿瘤的基础与临床研究[J].第三军医大学学报,2009,31(13):1237-1238. 被引量:1
-
5杨昆,倪洪珍,王懿辉.老男人,莫为“腺”所困[J].名医,2013(3):55-56.
-
6马腾骧.男生殖系肿瘤[J].中华泌尿外科杂志,1999,20(9):520-523. 被引量:16
-
7于黎明,李际春,杜传馨,芦晓红.女性生殖系统恶性肿瘤患者血中SOD和MDA含量的测定及评价[J].宁夏医学杂志,1998,20(4):229-230.
-
8周宇.人乳头瘤病毒与消化道肿瘤[J].国外医学(内科学分册),1995,22(10):440-442. 被引量:1
-
9孙光.泌尿、男生殖系肿瘤[J].开卷有益(求医问药),2006(7):6-7.
-
10顾晋,李明.我国直肠癌诊断和治疗的现状[J].中华消化外科杂志,2009,8(5):321-323. 被引量:12